doi: 10.1056/NEJMhle1311493.
New FDA breakthrough-drug category--implications for patients
- PMID: 24670173
- DOI: 10.1056/NEJMhle1311493
Item in Clipboard
New FDA breakthrough-drug category--implications for patients
N Engl J Med.
.
Free article
Erratum in
- N Engl J Med. 2014 Jul 3;371(1):94
No abstract available
Comment in
-
New FDA breakthrough-drug category--implications for patients.N Engl J Med. 2014 Jul 3;371(1):89-90. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988576 No abstract available.
-
New FDA breakthrough-drug category--implications for patients.N Engl J Med. 2014 Jul 3;371(1):87-8. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988577 No abstract available.
-
New FDA breakthrough-drug category--implications for patients.N Engl J Med. 2014 Jul 3;371(1):88. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988578 No abstract available.
-
New FDA breakthrough-drug category--implications for patients.N Engl J Med. 2014 Jul 3;371(1):88-9. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988579 No abstract available.
-
New FDA breakthrough-drug category--implications for patients.N Engl J Med. 2014 Jul 3;371(1):89. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988580 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
